Skip to content

Clinical trials

Phase 3 Obesity trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Obesity Phase: Phase 3 Country / region: United States Clear all

255 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20014
20022
20034
20045
20055
200612
200713
20089
20097
20104
20118
20126
20135
20143
20152
20166
20177
20189
20197
202113
20229
202319
202411
202527
202653

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed139
Recruiting48
Active, not recruiting32
Terminated13
Not yet recruiting11
Unknown status7
Withdrawn3
Suspended2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S50
Eli Lilly and Company46
Amgen10
Pfizer9
Boehringer Ingelheim8
Sanofi8
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)6
Orexigen Therapeutics, Inc6
Hoffmann-La Roche5
Mayo Clinic5

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Obesity255
Overweight107
Diabetes Mellitus, Type 238
Weight Loss20
Nutrition Disorders19
Diabetes Mellitus15
Cardiovascular Diseases10
Sleep Apnea, Obstructive10
Body Weight7
Hypertension7

Trials

Showing 1 to 25 of 255. Each trial links to its page on Pharma Observatory.

155 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.